IP Verse

Ventana Medical Systems, Inc. opposition analysis

COMPANY ANALYSIS

Patent:

Grant Date:

Jan 19, 2022

Title:

Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3

Oppositions:

Patent:

Grant Date:

Jan 9, 2019

Title:

Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L1

Oppositions:

Patent:

Grant Date:

May 17, 2017

Title:

Method Of Identifying Treatment Responsive Non-Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (Alk) As A Marker

Oppositions:

Patent Number	Grant Date	Title	Total Oppositions
EP3111221	Jan 19, 2022	Methods, Kits, And Systems For Scoring The Immune Response To Cancer By Simultaneous Detection Of Cd3, Cd8, Cd20 And Foxp3	1
EP3149481	Jan 9, 2019	Multiplex Assay For Improved Scoring Of Tumor Tissues Stained For Pd-L1	1
EP2898329	May 17, 2017	Method Of Identifying Treatment Responsive Non-Small Cell Lung Cancer Using Anaplastic Lymphoma Kinase (Alk) As A Marker	1

CMS CAMERON MCKENNA NABARRO OLSWANG LLP

HOFFMANN EITLE

Feel free to send us a message here and we will get back to you